Seizures are a known side effect of nicotine toxicity, and the FDA has received reports about adverse events linked to tobacco use since 1988.
The agency has noticed an uptick in reports of seizures. After assessing poison control centers’ reports between 2010 and early 2019 as well as events reported to the FDA, it found 35 reported cases of seizures mentioning use of e-cigarettes. Since the reports are voluntary, the agency noted there may have been more incidences of seizures among e-cigarettes users.
The FDA is asking for more information about seizures after e-cigarette use to examine common risk factors and determine whether any particular product attributes are linked to the seizures. They urge e-cigarette users to report adverse events via the Safety Reporting Portal.
More articles on population health:
Key nonmedical barriers to care that hospital leaders plan to address this year
FDA to limit sale of flavored e-cigarettes: 3 things to know
Kaiser Permanente broadens effort address chronic homelessness
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
